Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:AZIHF NYSE:BTT NYSE:CDI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAZIHFAzimut$37.91-0.6%$35.42$22.21▼$38.37N/AN/A1,236 shs374 shsBTTBlackrock Municipal 2030 Target Term Trust$22.53-0.1%$22.25$20.20▼$22.74N/AN/A129,827 shs161,720 shsCDICDI$8.22$0.00$4.84▼$9.65N/AN/A81,650 shsN/AThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAZIHFAzimut+0.61%-0.60%+5.21%+22.24%+65.32%BTTBlackrock Municipal 2030 Target Term Trust-0.18%+0.00%+1.35%+4.33%+3.94%CDICDI0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAZIHFAzimut$37.91-0.6%$35.42$22.21▼$38.37N/AN/A1,236 shs374 shsBTTBlackrock Municipal 2030 Target Term Trust$22.53-0.1%$22.25$20.20▼$22.74N/AN/A129,827 shs161,720 shsCDICDI$8.22$0.00$4.84▼$9.65N/AN/A81,650 shsN/AThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAZIHFAzimut+0.61%-0.60%+5.21%+22.24%+65.32%BTTBlackrock Municipal 2030 Target Term Trust-0.18%+0.00%+1.35%+4.33%+3.94%CDICDI0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAZIHFAzimut 0.00N/AN/AN/ABTTBlackrock Municipal 2030 Target Term Trust 0.00N/AN/AN/ACDICDI 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAZIHFAzimutN/AN/AN/AN/AN/AN/ABTTBlackrock Municipal 2030 Target Term Trust$38.06MN/AN/AN/AN/AN/ACDICDIN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAZIHFAzimutN/A$1.2829.64∞N/AN/AN/AN/A11/6/2025 (Estimated)BTTBlackrock Municipal 2030 Target Term TrustN/AN/A0.00∞N/AN/AN/AN/A10/1/2025 (Estimated)CDICDIN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAZIHFAzimut$0.080.21%N/A6.26%N/ABTTBlackrock Municipal 2030 Target Term Trust$0.321.42%N/AN/AN/ACDICDIN/AN/AN/AN/AN/ALatest AZIHF, BTT, CDI, DP3D, and TBGR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date9/2/2025BTTBlackrock Municipal 2030 Target Term Trustmonthly$0.04642.47%9/15/20259/15/202510/1/20258/1/2025BTTBlackrock Municipal 2030 Target Term Trustmonthly$0.04642.5%8/15/20258/15/20259/2/20257/1/2025BTTBlackrock Municipal 2030 Target Term Trustmonthly$0.04642.5%7/15/20257/15/20257/31/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAZIHFAzimut40.29%BTTBlackrock Municipal 2030 Target Term TrustN/ACDICDI35.88%Insider OwnershipCompanyInsider OwnershipAZIHFAzimutN/ABTTBlackrock Municipal 2030 Target Term TrustN/ACDICDI8.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAZIHFAzimut1,698N/AN/ANot OptionableBTTBlackrock Municipal 2030 Target Term TrustN/AN/AN/ANot OptionableCDICDIN/AN/AN/ANot OptionableAZIHF, BTT, CDI, DP3D, and TBGR HeadlinesRecent News About These CompaniesCDI Lab, HMH Experts Uncover Key Cellular Immunity PathwaySeptember 17 at 4:56 PM | miragenews.comMScientists discover proteins that initiate cellular immunity in bone marrowSeptember 17 at 4:56 PM | msn.comCOCP: CDI-988 Showcased at Calicivirus Conference; Direct Offering Raises Up to $13 Million…September 17 at 4:56 PM | finance.yahoo.comDairy Foods announces 2025 Dairy Plant of the YearSeptember 17 at 6:21 AM | dairyfoods.comDChurchill Downs Incorporated 2025 Third Quarter Financial Results Conference Call InvitationSeptember 16 at 8:19 PM | markets.businessinsider.comChina Development Institute (China)September 15 at 3:19 AM | scmp.comCocrystal Pharma Advances CDI-988 to Phase 1b StudySeptember 12, 2025 | tipranks.comCocrystal Pharma showcases CDI-988, antiviral for norovirus infectionSeptember 12, 2025 | msn.comCocrystal Pharma Presents Clinical Progress of CDI-988, a Novel Antiviral for Norovirus, at 9th International Calicivirus ConferenceSeptember 12, 2025 | quiverquant.comQGQG Partners Director Increases Stake with Significant CDI AcquisitionSeptember 11, 2025 | tipranks.comFecal Microbiota, Live-Jslm Safe and Effective for rCDI in Patients With and Without IBSSeptember 9, 2025 | infectiousdiseaseadvisor.comIFecal Microbiota, Live-Jslm Safe and Effective for rCDI in Patients With and Without IBSSeptember 9, 2025 | infectiousdiseaseadvisor.comICocrystal Pharma’s norovirus antiviral study receives FDA clearanceSeptember 9, 2025 | msn.comCocrystal Pharma Receives FDA IND Clearance for Challenge Study of Oral Broad-Spectrum Protease Inhibitor CDI-988, a Potential First Antiviral for Norovirus Prevention and ...September 8, 2025 | finance.yahoo.comMercedes C220 CDI W205 – Acceleration & KickdownSeptember 8, 2025 | msn.comMercedes C220 CDI W205 – Autobahn Drive ViewSeptember 8, 2025 | msn.comC220 CDI W205 – City Drive & Fuel UsageSeptember 7, 2025 | msn.comDo call it a comeback for milkSeptember 6, 2025 | dairyfoods.comDSouthern Cross Gold Reports Decrease in CDIs for August 2025September 4, 2025 | tipranks.comAnteris Technologies Reports Changes in Securities IssuanceSeptember 4, 2025 | tipranks.comMedia Sentiment Over TimeAZIHF, BTT, CDI, DP3D, and TBGR Company DescriptionsAzimut OTCMKTS:AZIHF$37.91 -0.23 (-0.60%) As of 11:17 AM EasternAzimut Holding S.p.A. engages in the asset management business. It distributes, manages, and promotes financial and insurance products in Italy, Luxembourg, Ireland, Hong Kong, Shanghai, Principality of Monaco, Switzerland, Singapore, Brazil, Mexico, Taiwan, Chile, the United States, Australia, Turkey, the United Arab Emirates, Egypt, and Portugal. The company also promotes and manages Italian mutual funds, Italian alternative investment funds, and open-ended pension funds, as well as provides investment portfolio individual management services on behalf of third parties; and distributes group and third-party products in Italy through a network of financial advisors. In addition, it manages multi strategy funds; and offers life insurance products. Azimut Holding S.p.A. was incorporated in 1990 and is based in Milan, Italy.Blackrock Municipal 2030 Target Term Trust NYSE:BTT$22.52 -0.03 (-0.11%) Closing price 03:57 PM EasternExtended Trading$22.52 0.00 (0.00%) As of 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Blackrock Municipal 2030 Target Term Trust is a closed end fixed income mutual fund launched by BlackRock, Inc. The fund is managed by by BlackRock Advisors, LLC. It invests in fixed income markets. The fund invests primarily in investment grade municipal bonds that are exempt from regular federal income tax. It was formerly known as BlackRock Municipal Target Term Trust. Blackrock Municipal 2030 Target Term Trust was formed on August 30, 2012 and is domiciled in the United States.CDI NYSE:CDICDI Corp. provides engineering, information technology and staffing solutions. The Company operates in three segments: Global Engineering and Technology Solutions (GETS), Professional Staffing Services (PSS) and Management Recruiters International (MRI). It provides staffing services through its MRINetwork of franchisees. The GETS segment provides engineering and information technology solutions that involve the production of deliverable work products or services performed at its facility or at a customer's facility. The PSS segment provides technical and professional personnel for discrete periods of time to augment the customer's workforce in times of project, seasonal, peak period or business cycle needs. The MRI segment is a global franchisor that does business as MRINetwork and provides the use of its trademarks, business systems and training and support services to its franchisees. It serves the oil, gas and chemicals, aerospace and industrial equipment, and hi-tech industries. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike’s Red-Hot Analyst Buzz: Is a Comeback Brewing? The Side of Rate Cuts Nobody Is Telling You About Broadcom Hits Record High After CEO Hock Tan AI Pay Package CrowdStrike Stock Set for Breakout as Agentic AI Demand Surges Why CoreWeave's NVIDIA Deal Creates a Deep Moat for AI Investors Dave & Buster’s Stock: Is Now the Time to Make a PLAY? Resideo Technologies: Institutional Activity Signals 30% Upside This Stock Quietly Benefits From Oracle and NVIDIA’s AI Surge Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
